
|Articles|November 1, 2004
Wart treatment shows excellent safety, efficacy
New York - Topical 5-fluorouracil 5 percent cream (Efudex, Valeant) appears to be a low-risk, low-cost, rapidly effective and well-tolerated treatment for common warts in children, according to the results of a pilot study presented by Bari B. Cunningham, M.D., at the American Academy of Dermatology's Academy `04, here this summer.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Christopher Bunick, MD, PhD, on Expanding Targets in Inflammatory Skin Disease
2
Mona Shahriari, MD, FAAD, on OX40-Targeted Therapy in AD
3
When Innovation Meets Insurance Barriers With Lisa Swanson, MD
4
GLP-1s and Skin Health: Clinical Pearls From Gold and Lal
5










